Cargando…

COVID-19 vaccine for people who live and work in prisons worldwide: A scoping review

Overcrowding, poor conditions, and high population turnover make prisons highly susceptible to COVID-19. Vaccination is key to controlling COVID-19, yet there is disagreement regarding whether people who live and work in prisons should be prioritised in national vaccination programmes. To help resol...

Descripción completa

Detalles Bibliográficos
Autores principales: Ismail, Nasrul, Tavoschi, Lara, Moazen, Babak, Roselló, Alicia, Plugge, Emma
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9462803/
https://www.ncbi.nlm.nih.gov/pubmed/36084037
http://dx.doi.org/10.1371/journal.pone.0267070
_version_ 1784787271628619776
author Ismail, Nasrul
Tavoschi, Lara
Moazen, Babak
Roselló, Alicia
Plugge, Emma
author_facet Ismail, Nasrul
Tavoschi, Lara
Moazen, Babak
Roselló, Alicia
Plugge, Emma
author_sort Ismail, Nasrul
collection PubMed
description Overcrowding, poor conditions, and high population turnover make prisons highly susceptible to COVID-19. Vaccination is key to controlling COVID-19, yet there is disagreement regarding whether people who live and work in prisons should be prioritised in national vaccination programmes. To help resolve this, we critically examine the extent, nature, and quality of extant literature regarding prioritisation of COVID-19 vaccinations for people who live and work in prisons. Using a scoping review as our methodological framework, we conducted a systematic literature search of 17 databases. From 2,307 potentially eligible articles, we removed duplicates and screened titles and abstracts to retain 45 articles for review and quality appraisal. Findings indicated that while most countries recognise that prisons are at risk of high levels of COVID-19 transmission, only a minority have explicitly prioritised people who live and work in prisons for COVID-19 vaccination. Even among those that have, prioritisation criteria vary considerably. This is set against a backdrop of political barriers, such as politicians questioning the moral deservingness of people in prison; policy barriers, such as the absence of a unified international framework of how vaccine prioritisation should proceed in prisons; logistical barriers regarding vaccine administration in prisons; and behavioural barriers including vaccine hesitancy. We outline five strategies to prioritise people who live and work in prisons in COVID-19 vaccination plans: (1) improving data collection on COVID-19 vaccination, (2) reducing the number of people imprisoned, (3) tackling vaccine populism through advocacy, (4) challenging arbitrary prioritisation processes via legal processes, and (5) conducting more empirical research on COVID-19 vaccination planning, delivery, and acceptability. Implementing these strategies would help to reduce the impact of COVID-19 on the prison population, prevent community transmission, improve vaccine uptake in prisons beyond the current pandemic, foster political accountability, and inform future decision-making.
format Online
Article
Text
id pubmed-9462803
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-94628032022-09-10 COVID-19 vaccine for people who live and work in prisons worldwide: A scoping review Ismail, Nasrul Tavoschi, Lara Moazen, Babak Roselló, Alicia Plugge, Emma PLoS One Research Article Overcrowding, poor conditions, and high population turnover make prisons highly susceptible to COVID-19. Vaccination is key to controlling COVID-19, yet there is disagreement regarding whether people who live and work in prisons should be prioritised in national vaccination programmes. To help resolve this, we critically examine the extent, nature, and quality of extant literature regarding prioritisation of COVID-19 vaccinations for people who live and work in prisons. Using a scoping review as our methodological framework, we conducted a systematic literature search of 17 databases. From 2,307 potentially eligible articles, we removed duplicates and screened titles and abstracts to retain 45 articles for review and quality appraisal. Findings indicated that while most countries recognise that prisons are at risk of high levels of COVID-19 transmission, only a minority have explicitly prioritised people who live and work in prisons for COVID-19 vaccination. Even among those that have, prioritisation criteria vary considerably. This is set against a backdrop of political barriers, such as politicians questioning the moral deservingness of people in prison; policy barriers, such as the absence of a unified international framework of how vaccine prioritisation should proceed in prisons; logistical barriers regarding vaccine administration in prisons; and behavioural barriers including vaccine hesitancy. We outline five strategies to prioritise people who live and work in prisons in COVID-19 vaccination plans: (1) improving data collection on COVID-19 vaccination, (2) reducing the number of people imprisoned, (3) tackling vaccine populism through advocacy, (4) challenging arbitrary prioritisation processes via legal processes, and (5) conducting more empirical research on COVID-19 vaccination planning, delivery, and acceptability. Implementing these strategies would help to reduce the impact of COVID-19 on the prison population, prevent community transmission, improve vaccine uptake in prisons beyond the current pandemic, foster political accountability, and inform future decision-making. Public Library of Science 2022-09-09 /pmc/articles/PMC9462803/ /pubmed/36084037 http://dx.doi.org/10.1371/journal.pone.0267070 Text en © 2022 Ismail et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Ismail, Nasrul
Tavoschi, Lara
Moazen, Babak
Roselló, Alicia
Plugge, Emma
COVID-19 vaccine for people who live and work in prisons worldwide: A scoping review
title COVID-19 vaccine for people who live and work in prisons worldwide: A scoping review
title_full COVID-19 vaccine for people who live and work in prisons worldwide: A scoping review
title_fullStr COVID-19 vaccine for people who live and work in prisons worldwide: A scoping review
title_full_unstemmed COVID-19 vaccine for people who live and work in prisons worldwide: A scoping review
title_short COVID-19 vaccine for people who live and work in prisons worldwide: A scoping review
title_sort covid-19 vaccine for people who live and work in prisons worldwide: a scoping review
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9462803/
https://www.ncbi.nlm.nih.gov/pubmed/36084037
http://dx.doi.org/10.1371/journal.pone.0267070
work_keys_str_mv AT ismailnasrul covid19vaccineforpeoplewholiveandworkinprisonsworldwideascopingreview
AT tavoschilara covid19vaccineforpeoplewholiveandworkinprisonsworldwideascopingreview
AT moazenbabak covid19vaccineforpeoplewholiveandworkinprisonsworldwideascopingreview
AT roselloalicia covid19vaccineforpeoplewholiveandworkinprisonsworldwideascopingreview
AT pluggeemma covid19vaccineforpeoplewholiveandworkinprisonsworldwideascopingreview